financetom
Business
financetom
/
Business
/
Macy's Fiscal Q3 Adjusted Earnings, Revenue Fall; Fiscal 2024 Guidance Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Macy's Fiscal Q3 Adjusted Earnings, Revenue Fall; Fiscal 2024 Guidance Revised
Dec 11, 2024 4:53 AM

07:23 AM EST, 12/11/2024 (MT Newswires) -- Macy's (M) reported fiscal Q3 adjusted earnings Wednesday of $0.04 per diluted share, down from $0.21 a year earlier.

Analysts polled by FactSet expected $0.03.

Total revenue for the quarter ended Nov. 2 was $4.90 billion, down from $5.04 billion a year earlier.

A single analyst surveyed by FactSet expected $4.74 billion.

For fiscal 2024, Macy's said it now expects adjusted diluted EPS in the range of $2.25 to $2.50, down from its prior outlook of $2.55 to $2.90. Analysts polled by FactSet expect $2.73.

Net sales for the fiscal year are now projected to be between $22.3 billion and $22.5 billion, compared with its previous range of $22.1 billion to $22.4 billion. Four analysts surveyed by FactSet expect $22.18 billion.

Shares of the company were down 9% in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vertiv Holdings Insider Sold Shares Worth $11,352,915, According to a Recent SEC Filing
Vertiv Holdings Insider Sold Shares Worth $11,352,915, According to a Recent SEC Filing
Nov 29, 2024
03:26 AM EST, 11/29/2024 (MT Newswires) -- Stephen Liang, Chief Technology Officer & Executive Vice President, on November 26, 2024, sold 86,619 shares in Vertiv Holdings ( VRT ) for $11,352,915. Following the Form 4 filing with the SEC, Liang has control over a total of 19,552 shares of the company, with 19,551 shares held directly and 1 controlled indirectly....
Nov 29, 2024
...
Protagonist Therapeutics Insider Sold Shares Worth $4,680,749, According to a Recent SEC Filing
Protagonist Therapeutics Insider Sold Shares Worth $4,680,749, According to a Recent SEC Filing
Nov 29, 2024
03:30 AM EST, 11/29/2024 (MT Newswires) -- Dinesh V Patel, Director, President and Chief Executive Officer, on November 25, 2024, sold 100,000 shares in Protagonist Therapeutics ( PTGX ) for $4,680,749. Following the Form 4 filing with the SEC, Patel has control over a total of 408,455 shares of the company, with 408,455 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465924123806/xslF345X05/tm2429758-1_4seq1.xml ...
Protagonist Therapeutics Insider Sold Shares Worth $1,414,402, According to a Recent SEC Filing
Protagonist Therapeutics Insider Sold Shares Worth $1,414,402, According to a Recent SEC Filing
Nov 29, 2024
03:29 AM EST, 11/29/2024 (MT Newswires) -- Arturo Molina, Chief Medical Officer, on November 26, 2024, sold 31,529 shares in Protagonist Therapeutics ( PTGX ) for $1,414,402. Following the Form 4 filing with the SEC, Molina has control over a total of 46,444 shares of the company, with 46,444 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465924123809/xslF345X05/tm2429758-3_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved